Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Status unconfirmed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than once drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel plus estramustine in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Key facts

Study ID

NCT00003717

Run by

St. Barnabas Medical Center

People needed

17

Starts

1998-10-01

Last updated by the study team

2013-12-19

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

• St. Barnabas Medical Center — Livingston, New Jersey, United States
• Monmouth Medical Center — Long Branch, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.